166 related articles for article (PubMed ID: 31969767)
21. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study.
Suzuki Y; Yoshimura N; Saniabadi AR; Saito Y
Dig Dis Sci; 2004 Apr; 49(4):565-71. PubMed ID: 15185858
[TBL] [Abstract][Full Text] [Related]
22. [Remission by leukocytapheresis for a patient with ulcerative colitis found refractory by conventional drug therapies].
Sawada K; Ohnishi K; Kosaka T; Egashira A; Kinoshita T; Amano K; Yamamura M; Satomi M; Shimoyama T
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):126-33. PubMed ID: 9178970
[TBL] [Abstract][Full Text] [Related]
23. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
Kinugasa T; Akagi Y; Murotani K; Romeo K; Yoshida T; Ryu Y; Shiratuchi I; Shirouzu K
Anticancer Res; 2011 Jul; 31(7):2547-52. PubMed ID: 21873173
[TBL] [Abstract][Full Text] [Related]
24. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.
Sawada K; Muto T; Shimoyama T; Satomi M; Sawada T; Nagawa H; Hiwatashi N; Asakura H; Hibi T
Curr Pharm Des; 2003; 9(4):307-21. PubMed ID: 12570823
[TBL] [Abstract][Full Text] [Related]
25. Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy.
Fukunaga K; Fukuda Y; Sawada K; Hori K; Matoba Y; Sagayama K; Ohnishi K; Fukui S; Shimoyama T
J Gastroenterol; 2003; 38(7):684-9. PubMed ID: 12898362
[TBL] [Abstract][Full Text] [Related]
26. Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis.
Yamasaki S; Sakata Y; Yoshida H; Shirai S; Tanaka Y; Nakano R; Yukimoto T; Tsuruoka N; Shimoda R; Fukuda M; Miyazono M; Ikeda Y; Iwakiri R; Anzai K; Fujimoto K
Digestion; 2019; 100(4):247-253. PubMed ID: 30540999
[TBL] [Abstract][Full Text] [Related]
27. A case report: first case of filtration leukocytapheresis for a patient of aortitis syndrome associated with ulcerative colitis.
Fukunaga K; Sawada K; Fukuda Y; Matoba Y; Onishi K; Fukui S; Yamamura M; Satomi M; Shimoyama T
Ther Apher; 2002 Feb; 6(1):93-8. PubMed ID: 11886584
[TBL] [Abstract][Full Text] [Related]
28. Extracorporeal leukocyte removal therapy for patients with ulcerative colitis.
Kumagai M; Yamato Y; Maeda K; Nakashima E; Ushijima K; Kimura A
Pediatr Int; 2007 Aug; 49(4):431-6. PubMed ID: 17587263
[TBL] [Abstract][Full Text] [Related]
29. Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry.
Cabriada JL; Domènech E; Ibargoyen N; Hernández V; Clofent J; Ginard D; Gutiérrez-Ibarluzea I; Hinojosa J
J Gastroenterol; 2012 Apr; 47(4):359-65. PubMed ID: 22105230
[TBL] [Abstract][Full Text] [Related]
30. [Leukocytapheresis for ulcerative colitis].
Sawada K; Ohnishi K; Kosaka T; Egashira A; Yamamura M; Satomi M; Shimoyama T
Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):438-42. PubMed ID: 9168498
[TBL] [Abstract][Full Text] [Related]
31. Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients.
Fukunaga K; Fukuda Y; Yokoyama Y; Ohnishi K; Kusaka T; Kosaka T; Hida N; Ohda Y; Miwa H; Matsumoto T
J Gastroenterol; 2006 Jun; 41(6):524-32. PubMed ID: 16868799
[TBL] [Abstract][Full Text] [Related]
32. Safety and Tolerability of Nafamostat Mesilate and Heparin as Anticoagulants in Leukocytapheresis for Ulcerative Colitis: Post Hoc Analysis of a Large-Scale, Prospective, Observational Study.
Sawada K; Ohdo M; Ino T; Nakamura T; Numata T; Shibata H; Sakou J; Kusada M; Hibi T
Ther Apher Dial; 2016 Apr; 20(2):197-204. PubMed ID: 26771066
[TBL] [Abstract][Full Text] [Related]
33. Leukocytapheresis in pediatric patients with ulcerative colitis.
Tomomasa T; Tajiri H; Kagimoto S; Shimizu T; Yoden A; Ushijima K; Uchida K; Kaneko H; Abukawa D; Konno M; Maisawa S; Kohsaka T; Kobayashi A;
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):34-9. PubMed ID: 21694533
[TBL] [Abstract][Full Text] [Related]
34. Influence of leukocytapheresis therapy for ulcerative colitis on anemia and hemodynamics.
Miyamoto H; Okahisa T; Iwaki H; Murata M; Ito S; Nitta Y; Akutagawa M; Kinouchi Y; Ohnishi Y; Oto J; Nishimura M
Ther Apher Dial; 2007 Feb; 11(1):16-21. PubMed ID: 17309570
[TBL] [Abstract][Full Text] [Related]
35. [A case of tacrolimus plus intensive LCAP therapy combination for refractory ulcerative colitis].
Matsumoto A; Yajima H; Murata T; Gotou K; Okamoto K; Nishiyama H
Nihon Shokakibyo Gakkai Zasshi; 2013 Apr; 110(4):639-47. PubMed ID: 23558127
[TBL] [Abstract][Full Text] [Related]
36. Leukocytapheresis therapy for severe ulcerative colitis.
Sasaki M; Tsujikawa T; Fujiyama Y; Bamba T
Ther Apher; 1998 May; 2(2):101-4. PubMed ID: 10225708
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal elimination of TNF-alpha-producing CD14(dull)CD16(+) monocytes in leukocytapheresis therapy for ulcerative colitis.
Kanai T; Makita S; Kawamura T; Nemoto Y; Kubota D; Nagayama K; Totsuka T; Watanabe M
Inflamm Bowel Dis; 2007 Mar; 13(3):284-90. PubMed ID: 17206704
[TBL] [Abstract][Full Text] [Related]
38. Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis.
Andoh A; Ogawa A; Kitamura K; Inatomi O; Fujino S; Tsujikawa T; Sasaki M; Mitsuyama K; Fujiyama Y
J Gastroenterol; 2004 Dec; 39(12):1150-7. PubMed ID: 15622478
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of leukocytapheresis in suppressing the occurrence of surgical site infections following surgery for ulcerative colitis.
Itabashi M; Ikeuchi H; Araki T; Kono T; Nakamura T; Takesue Y; Kameoka S; Kusunoki M
Surg Today; 2008; 38(7):609-17. PubMed ID: 18612785
[TBL] [Abstract][Full Text] [Related]
40. Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis.
Okuyama Y; Andoh A; Nishishita M; Fukunaga K; Kamikozuru K; Yokoyama Y; Ueno Y; Tanaka S; Kuge H; Yoshikawa S; Sugahara A; Anami E; Munetomo Y; Watanabe C; Fujiyama Y; Matsumoto T
Scand J Gastroenterol; 2013 Apr; 48(4):412-8. PubMed ID: 23356660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
